Saarinen P, Jokelainen O, Ruotsalainen L, Ikonen E, Nykopp T
Discov Oncol. 2025; 16(1):95.
PMID: 39870906
PMC: 11772899.
DOI: 10.1007/s12672-025-01828-5.
Radulovic M, Cimerman D, Flezar M
Diagn Cytopathol. 2024; 53(4):173-180.
PMID: 39727103
PMC: 11874206.
DOI: 10.1002/dc.25434.
Head D, Raman J
J Clin Med. 2024; 13(21).
PMID: 39518735
PMC: 11546368.
DOI: 10.3390/jcm13216593.
Carbonell E, Mercader C, Alfambra H, Narvaez P, Villalba E, Pages R
Cancers (Basel). 2024; 16(21).
PMID: 39518145
PMC: 11545547.
DOI: 10.3390/cancers16213708.
Wei W, Fan P, Zhang Z, Wu D, Liu J, Wang L
BMC Cancer. 2024; 24(1):1180.
PMID: 39333973
PMC: 11438001.
DOI: 10.1186/s12885-024-12913-3.
Correlation between urine cytology results on the day after overnight continuous saline irrigation following transurethral resection of bladder tumor and bladder tumor recurrence.
Kim D, Choi M, Choi J, Lee C, Jeh S, Kam S
Investig Clin Urol. 2024; 65(3):279-285.
PMID: 38714518
PMC: 11076798.
DOI: 10.4111/icu.20230284.
Development and validation of an artificial intelligence-based model for detecting urothelial carcinoma using urine cytology images: a multicentre, diagnostic study with prospective validation.
Wu S, Shen R, Hong G, Luo Y, Wan H, Feng J
EClinicalMedicine. 2024; 71:102566.
PMID: 38686219
PMC: 11056596.
DOI: 10.1016/j.eclinm.2024.102566.
Utility of the Paris System in Urine Cytology for Improved Screening of High-Grade Urothelial Carcinoma in Bahrain.
Daoud R, Ali A, Salim Fredericks S, Daoud S, Gomaa H, AlHashimi F
Cureus. 2024; 16(3):e57189.
PMID: 38681345
PMC: 11056096.
DOI: 10.7759/cureus.57189.
Cross-sectional and longitudinal analyses of urinary extracellular vesicle mRNA markers in urothelial bladder cancer patients.
Murakami T, Minami K, Harabayashi T, Maruyama S, Takada N, Kashiwagi A
Sci Rep. 2024; 14(1):6801.
PMID: 38514751
PMC: 10957914.
DOI: 10.1038/s41598-024-55251-x.
Novel urine-based DNA methylation biomarkers for urothelial bladder carcinoma detection in patients with hematuria.
Abol-Elnazer H, Awadalla A, Ahmed A, Abol-Enein H, Al Ganzouri M, Elsawy A
Arab J Urol. 2024; 21(4):248-257.
PMID: 38178946
PMC: 10763582.
DOI: 10.1080/2090598X.2023.2208492.
Urinary Diagnostic Cytology Beyond the Research of Neoplastic Cells: Usefulness of Erythrocyte Morphology Evaluation to Recognize Microhematuria Source.
Del Sordo R, Covarelli C, Annese L, Mandarano M, Bellezza G, Sidoni A
J Cytol. 2023; 40(4):200-204.
PMID: 38058666
PMC: 10697315.
DOI: 10.4103/joc.joc_159_22.
Diagnostic Significance of Cytokeratin 20 and p53 as Adjunct Immunocytological Markers in Urine Cytology to Detect Urothelial Carcinomas: A Systematic Review Study.
Angel E
Iran J Pathol. 2023; 18(3):257-269.
PMID: 37942190
PMC: 10628378.
DOI: 10.30699/IJP.2023.1972203.3004.
Diagnosis, workup, and risk stratification of upper tract urothelial carcinoma.
Zganjar A, Thiel D, Lyon T
Transl Androl Urol. 2023; 12(9):1456-1468.
PMID: 37814699
PMC: 10560346.
DOI: 10.21037/tau-23-45.
MCM4 expression is associated with high-grade histology, tumor progression and poor prognosis in urothelial carcinoma.
Kobayashi G, Hayashi T, Sentani K, Uraoka N, Fukui T, Kido A
Diagn Pathol. 2023; 18(1):106.
PMID: 37737200
PMC: 10515259.
DOI: 10.1186/s13000-023-01392-y.
Is a Single Nephrographic Phase Computed Tomography Sufficient for Detecting Urothelial Carcinoma in Patients with Visible Haematuria? A Prospective Paired Noninferiority Comparison.
Galtung K, Lauritzen P, Sandbaek G, Bay D, Ponzi E, Baco E
Eur Urol Open Sci. 2023; 55:1-10.
PMID: 37693732
PMC: 10485786.
DOI: 10.1016/j.euros.2023.06.005.
Consultation on UTUC II Stockholm 2022: diagnostics, prognostication, and follow-up-where are we today?.
Syden F, Baard J, Bultitude M, Keeley Jr F, Roupret M, Thomas K
World J Urol. 2023; 41(12):3395-3403.
PMID: 37540248
PMC: 10693525.
DOI: 10.1007/s00345-023-04530-9.
Artificial intelligence to improve cytology performance in urothelial carcinoma diagnosis: results from validation phase of the French, multicenter, prospective VISIOCYT1 trial.
Lebret T, Paoletti X, Pignot G, Roumiguie M, Colombel M, Savareux L
World J Urol. 2023; 41(9):2381-2388.
PMID: 37480491
PMC: 10465399.
DOI: 10.1007/s00345-023-04519-4.
Limited Value of Bladder Wash Cytology During Follow-Up of Patients With Non-muscle Invasive Bladder Cancer.
Bieri U, Kranzbuhler B, Wettstein M, Fankhauser C, Kaufmann B, Seifert B
Cureus. 2023; 15(6):e40283.
PMID: 37448431
PMC: 10336741.
DOI: 10.7759/cureus.40283.
Large-scale validation study of an improved semiautonomous urine cytology assessment tool: AutoParis-X.
Levy J, Chan N, Marotti J, Kerr D, Gutmann E, Glass R
Cancer Cytopathol. 2023; 131(10):637-654.
PMID: 37377320
PMC: 11251731.
DOI: 10.1002/cncy.22732.
Examining longitudinal markers of bladder cancer recurrence through a semiautonomous machine learning system for quantifying specimen atypia from urine cytology.
Levy J, Chan N, Marotti J, Rodrigues N, Ismail A, Kerr D
Cancer Cytopathol. 2023; 131(9):561-573.
PMID: 37358142
PMC: 10527805.
DOI: 10.1002/cncy.22725.